Table 2 Demographic characteristics of the participants
Supplementation group (n = 103) | Placebo group (n =112) | P | |
|---|---|---|---|
Mean age in years | 37+/-13 | 37.1+/-13 | 0.869 |
Number of females n (%) | 70 (68.0) | 71 (63.4) | 0.566 |
Education n (%) | |||
Primary | 73 (70.9) | 88 (78.5) | |
Secondary or better | 30 (29.1) | 24 (21.4) | 0.333 |
Mean Body Mass Index (kg/m 2 ) | 22.6+/-3.8 | 22.8+/-5.9 | 0.581 |
HIV positive n = 66 (%) | 32 (48.4) | 34 (51.5) | 0.592 |
Mean Middle Upper Arm Circumference (MUAC) | 27.3+/-3.3 | 27.4+/-4.2 | 0.705 |
Mean Body fat (kg) | 29.9+/-9.4 | 29.5+/-9.8 | 0.547 |
Mean Lean mass (kg) | 70.0+/-9.3 | 69.9+/-11.0 | 0.630 |
Median (IQR) follow up (months) | 18 (16–19) | 19 (18–20) | 0.0001 |
pH n = 121 | 3.3+/-2.2 | 3.2+/-2.2 | 0.881 |
Tobacco use n (%) | 15 (14.5) | 23 (20.5) | 0.286 |
Cannabis n (%) | 4 (3.8) | 2 (1.8) | 0.430 |
Alcohol n (%) | 18 (16.1) | ||
Everyday | 12 (11.6) | 18 (16.1) | |
Not every day | 39 (37.9) | 33 (29.5) | 0.661 |